Drug Safety

, Volume 25, Issue 14, pp 1005–1019

The Use and Safety of Non-Allopathic Indian Medicines

  • N.J. Gogtay
  • H.A. Bhatt
  • S.S. Dalvi
  • N.A. Kshirsagar
Review Article

Abstract

Non-allopathic Indian medicines, referred to elsewhere in the world as complementary and alternative medicine have gathered increasing recognition in recent years with regard to both treatment options and health hazards. Ayurveda, Siddha, Unani and homeopathy are practiced in India as non-allopathic systems. These systems comprise a wide range of therapeutic approaches that include diet, herbs, metals, minerals, precious stones and their combinations as well as nondrug therapies. Ayurveda is the oldest system of medicine in the world and by far the most commonly practiced form of non-allopathic medicine in India, particularly in rural India, where 70% of the population lives.

The difference between modern medicine and these systems stems from the fact that the knowledge base of many of the above systems, unlike Western medicine, is based on years of experience, observations, empiricism and intuition and has been handed down generations both through word of mouth and treatises. The focus on non-allopathic systems of medicine in India can be attributed to various causes including a need to revive a rich tradition, the dependency of 80% of the country’s population on these drugs, their easy availability, increasing worldwide use of these medicines, the lack of focused concerted scientific research and the abuse of these systems by quacks. Elsewhere, the increasing use of herbal products worldwide and the growth of the herbal product industry has led to increasing concern regarding their safety. The challenges in these non-allopathic systems relate to the patient, physician, regulatory authorities, the abuse/misuse of these medicines, quality and purity issues. Safety monitoring is mandated by a changing ecological environment, the use of insecticides, new manufacturing techniques, an as yet unregulated pharmaceutical industry, the availability of combinations of herbs over the counter and not mentioned in ancient Ayurvedic texts, and the need to look at the active principles of these medicines as potential chemotherapeutic agents.

The Indian traditional medicine industry has come a long way from the times when it was considered unnecessary to test these formulations prior to use, to the introduction of Good Manufacturing Practice guidelines for the industry. However, we still have a long way to go. The conflict between the traditional practitioners and the purists demanding evidence of safety and efficacy needs to be addressed. There is an urgent need for the practitioners of the allopathic and non-allopathic systems to work together to optimise the risk-benefit profile of these medicines.

References

  1. 1.
    Stickel F, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr 2000; 3: 501–8PubMedGoogle Scholar
  2. 2.
    Srinivasan P. National Health policy for traditional medicine. World Health Forum 1995; 16: 190–3PubMedGoogle Scholar
  3. 3.
    Lele RD. Ayurveda (ancient Indian system of medicine) and modern molecular medicine. J Assoc Physicians India 1999; 47: 625–8PubMedGoogle Scholar
  4. 4.
    Singh RH. The holistic principles of Ayurvedic medicine. 1st ed. Varanasi (India): Chaukhamba Sanskrit Pratishthan, 1998Google Scholar
  5. 5.
    Trevelyan J. Complementary medicine: herbal medicine. Nurs Times 1993; 89: 36–8PubMedGoogle Scholar
  6. 6.
    Mishra L, Singh BB, Dagenais S. Ayurveda: a historical perspective and principles of the traditional healthcare system in India. Altern Ther Health Med 2001; 7: 36–42PubMedGoogle Scholar
  7. 7.
    Lenora RB. Ayurveda medicine. Clin Pediatr (Phila) 1968; 7: 239–42CrossRefGoogle Scholar
  8. 8.
    Bhishagaratna KK. Sushruta Samhita. Vol 1, 1st ed. Varanasi (India): Chowkhamba Sanskrit Series Office, 1998Google Scholar
  9. 9.
    Dahanukar SA, Thatte UM, Rege NN. Pharmacology in Ayurveda: introduction. Indian Pract 1998; 5: 409–11Google Scholar
  10. 10.
    Subbarayappa BV. Siddha medicine: an overview. Lancet 1997; 350: 1841–4PubMedCrossRefGoogle Scholar
  11. 11.
    Satyavati GV. Some traditional medical systems and practices of global importance. Indian J Med Res 1982; 76: 1–26PubMedGoogle Scholar
  12. 12.
    Mahabir RC, Son-Hing J, Tam AL, et al. Ancient Indian civilization: ahead by a nose. J Invest Surg 2001; 14: 3–5PubMedCrossRefGoogle Scholar
  13. 13.
    Zollman C, Vickers A. What is complementary medicine? BMJ 1999; 319: 693–6PubMedCrossRefGoogle Scholar
  14. 14.
    Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. Geneva: World Health Organization, WHO/EDM/TRM/2001.2Google Scholar
  15. 15.
    Nayak B. Ayurmedline. Ayurvedic drug index. Ayurmedline, Bangalore (India). Jan-Jun, 2001Google Scholar
  16. 16.
    Vaidya AB, Vaidya RA, Nagral SI. Ayurveda and a different kind of evidence: from Lord Macaulay to Lord Walton (1835 to 2001 AD). J Assoc Physicians India 2001; 49: 534–7PubMedGoogle Scholar
  17. 17.
    WHO. Regulatory situation of herbal medicine: a worldwide review. Geneva: World Health Organization, WHO/TRM/98.1Google Scholar
  18. 18.
    Astin JA. Why patients use alternative medicine. JAMA 1998; 279: 1548–53PubMedCrossRefGoogle Scholar
  19. 19.
    Furnham A. Why people choose complementary medicine. In: Andritzky W, editor. Yearbook of cross cultural medicine and psychotherapy. Berlin: VWB, 1994: 165–8Google Scholar
  20. 20.
    Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-97. JAMA 1998; 280: 1569–75PubMedCrossRefGoogle Scholar
  21. 21.
    Dahanukar SA, Thatte UM, Rege NN. Pharmacology in Ayurveda: VI. Adverse reactions to Ayurvedic drugs. Indian Pract 1998; 51: 815–21Google Scholar
  22. 22.
    Chopra A, Doiphode V. Ayurvedic medicine. Med Clin North Am 2002; 86: 75–89PubMedCrossRefGoogle Scholar
  23. 23.
    Okamato T, Hino O. Drug development with hints from traditional Indian Ayurveda medicine: hepatitis and rheumatoid arthritis as an example. Int J Mol Med 2000; 6: 613–5Google Scholar
  24. 24.
    Dandekar UP, Chandra RS, Dalvi SS, et al. Analysis of a clinical important interaction between phenytoin and shankhapushpi, an ayurvedic preparation. J Ethnopharmacol 1992; 35: 285–8PubMedCrossRefGoogle Scholar
  25. 25.
    Kshirsagar NA, Dalvi SS, Joshi MV, et al. Phenytoin and Ayurvedic preparation-clinically important interaction in epileptic patients. J Assoc Physicians India 1992; 40: 354–5PubMedGoogle Scholar
  26. 26.
    Garg SK, Islam AS, Kumar N, et al. Effect of Mentat on the pharmacokinetics of single and multiple doses of phenytoin in rabbits. Neurol India 1999; 47: 104–7PubMedGoogle Scholar
  27. 27.
    Koumaravelou K, Adithan C, Shashindran CH, et al. Effect of honey on carbamazepine kinetics in rabbits. Ind J Exp Biol 2002; 40: 560–3Google Scholar
  28. 28.
    Greeson JM. St John’s wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literature. Psychopharmacology (Berl) 2001; 153: 402–14CrossRefGoogle Scholar
  29. 29.
    Tomassoni AJ, Simone K. Herbal medicines for children: an illusion of safety? Curr Opin Pediatr 2001; 13: 162–9PubMedCrossRefGoogle Scholar
  30. 30.
    LaFrance WC, Lauterbach EC, Coffey CE. The use of herbal alternative medicine in neuropsychiatry. J Neuropsychiatry Clin Neurosci 2000; 12: 177–92PubMedCrossRefGoogle Scholar
  31. 31.
    Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, gingko or ginseng: nature of the evidence. Ann Pharmacother 2000; 34: 1478–82PubMedGoogle Scholar
  32. 32.
    Ernst E, Pittler MH. The efficacy and safety of feverfew (tanacetum parthenium L): an update of a systematic review. Public Health Nutr 2000; 3: 509–14PubMedCrossRefGoogle Scholar
  33. 33.
    Fugh-Berman A, Ernst E. Herb-drug interactions: review of assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587–95PubMedCrossRefGoogle Scholar
  34. 34.
    Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs. Drugs 2001; 61(15): 2163–75PubMedCrossRefGoogle Scholar
  35. 35.
    Kshirsagar NA. Misleading herbal Ayurvedic brand name. Lancet 1993; 341: 1595–6PubMedCrossRefGoogle Scholar
  36. 36.
    Coppes MJ, Anderson RA, Egeler RM, et al. Alternative therapies for the treatment of childhood cancer. N Engl J Med 1998; 339: 846–7PubMedCrossRefGoogle Scholar
  37. 37.
    Sharma RK, Dash B. Charaka Samhita. 6th ed. Varanasi (India). Chaukhamba Sanskrit Studies, 1999Google Scholar
  38. 38.
    Subramaniam A. The problems and prospects of plant drug research in India: pharmacological evaluation of ecotypes in drug development. Indian J Pharmacol 2001; 33: 145–6Google Scholar
  39. 39.
    Marrone CM. Safety issues with herbal products. Ann Pharmacother 1999; 33: 1359–62PubMedCrossRefGoogle Scholar
  40. 40.
    Cui J, Garle M, Eneroth P, et al. What do commercial ginseng preparations contain [letter]. Lancet 1994; 344: 134PubMedCrossRefGoogle Scholar
  41. 41.
    Prabhu MS, Platel K, Saraswathi G, et al. Effect of orally administered betel leaf (Piper betle Linn.) on digestive enzymes of pancreas and intestinal mucosa and on bile production in rats. Indian J Exp Biol 1995; 33: 752–6PubMedGoogle Scholar
  42. 42.
    Slifman NR, Obermeyer WR, Aloi BK, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998; 339: 806–11PubMedCrossRefGoogle Scholar
  43. 43.
    Chan TY, Tomlinson B, Tse LK, et al. Aconitine poisoning due to Chinese herbal medicines: a review. Vet Hum Toxicol 1994; 36: 452–5PubMedGoogle Scholar
  44. 44.
    Gogtay NJ, Dalvi SS, Rane CT, et al. A story of Ayurvedic tablets and misled epileptic patients [letter]. J Assoc Physicians India 1999; 47: 1116PubMedGoogle Scholar
  45. 45.
    Gupta SK, Kaleekal T, Joshi S. Misuse of corticosteroids in some of the drugs dispensed as preparations from alternative systems of medicine in India. Pharmacoepidemiol Drug Saf 2000; 9: 599–602PubMedCrossRefGoogle Scholar
  46. 46.
    Chopra A. Ayurvedic medicine and arthritis. Rheum Dis Clin North Am 2000; 26: 133–44PubMedCrossRefGoogle Scholar
  47. 47.
    Joshi D. Rasamritam.1st ed. Varanasi (India): Chaukhambha Sanskrit Bhawan, 1998Google Scholar
  48. 48.
    Koh H, Woo S. Chinese proprietary medicine in Singapore. Drug Saf 2000; 23(5): 351–62PubMedCrossRefGoogle Scholar
  49. 49.
    Srikantha Murthy KR. Bhavprakash of Bhavmishra. 1st ed. Varanasi (India). Krishnadas Academy, 1998Google Scholar
  50. 50.
    Rai J. The indigenous digestive treatments: useful/harmful. Indian Pract 2002; 55: 27–8Google Scholar
  51. 51.
    Shrikanthamurthy KR. Ashtanga samgraha of Vagbhata (English Translation) Vol. 1, 5th ed. Varanasi (India). Chaukhambha Orientalia, 2002Google Scholar
  52. 52.
    Gogate VM. The text book of Ayurvedic pharmacology and therapeutics of medicinal plants. Mumbai (India). Bharatiya Vidya Bhawan, 2000Google Scholar
  53. 53.
    Sairam TV. Home remedies. Vol. IV. India: Penguin Books, 2002Google Scholar
  54. 54.
    Sharma DC. India raises standards for traditional drugs [letter]. Lancet 2000; 356: 231PubMedCrossRefGoogle Scholar
  55. 55.
    Notification of the Ministry of Health and Family Welfare (Department of Indian Systems of Medicine and Homeopathy). Jun 23, 2000Google Scholar
  56. 56.
    Angell M, Kassirer JP. Alternative medicine: the risks of untested and unregulated remedies. New Engl J Med 1998; 339: 839–41PubMedCrossRefGoogle Scholar
  57. 57.
    Margolin A. Investigating alternative medicine therapies in randomized controlled trials. JAMA 1998; 280: 1626–8PubMedCrossRefGoogle Scholar
  58. 58.
    Bhatt AD. Clinical research on Ayurvedic therapeutics: myths, realities and challenges. J Assoc Physicians India 2001; 49: 558–62PubMedGoogle Scholar
  59. 59.
    Antarkar DS, Vaidya AB, Doshi JC, et al. A double-blind clinical trial of Aarogyawardhini: an Ayurvedic drug in acute viral hepatitis. Indian J Med Res 1980; 72: 588–93PubMedGoogle Scholar
  60. 60.
    Bichile LS, Rajadhyaksha A, Kini S, et al. A double-blind randomized controlled trial of Sallaki (600mg) vs diclofenac sodium (50mg) in patients with rheumatoid arthritis. Indian Pract 2001; 54: 625–32Google Scholar
  61. 61.
    Lodha R, Bagga A. Traditional Indian system of medicine. Ann Acad Med Singapore 2000; 29: 37–41PubMedGoogle Scholar
  62. 62.
    Bajaj S, Vohora SB. Analgesic activity of gold preparations in Ayurveda and Unani. Indian J Med Res 1998; 108: 104–11PubMedGoogle Scholar
  63. 63.
    Kar A, Choudhary BK, Bandyopadhyay NG. Preliminary studies on the inorganic constituents of some indigenous hypoglycaemic herbs on oral glucose tolerance test. J Ethnopharmacol 1999; 64: 179–84PubMedCrossRefGoogle Scholar
  64. 64.
    Indian Council of Medical Research. Ethical guidelines for biomedical research on human subjects. New Delhi: Indian Council of Medical Research, 2000Google Scholar
  65. 65.
    Uchil D, Rege NN, Dahanukar SA. Modern correlates for ayurvedic quality control tests for tamra bhasma. Indian Drugs 1996; 33: 384–9Google Scholar
  66. 66.
    Rao SKR. Encyclopedia of Indian medicine. Bombay (India): Popular Prakashan, 1985Google Scholar
  67. 67.
    Lele RD. Ayurveda and modern medicine. Bombay (India): Bharatiya Vidya Bhawan, 1986Google Scholar
  68. 68.
    Tripathi YB. Molecular approach to Ayurveda. Indian J Exp Biol 2000; 38: 409–14PubMedGoogle Scholar
  69. 69.
    Bharatiya Vidya Bhavan’s SPARC. 111 selected medicinal plants of India. Bombay (India): CHEMEXCIL, 1992Google Scholar
  70. 70.
    Satakopan S. Quality control for Ayurvedic, Siddha and Unani drugs: attitudes and approaches. Ind Drugs 2000; 37: 114–8Google Scholar
  71. 71.
    Hesketh T, Zhu WX. Traditional Chinese medicine: one country, two systems. BMJ 1997; 315: 115–7PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  • N.J. Gogtay
    • 1
  • H.A. Bhatt
    • 1
  • S.S. Dalvi
    • 1
  • N.A. Kshirsagar
    • 1
  1. 1.Department of Clinical PharmacologySeth GS Medical College & KEM HospitalParelIndia

Personalised recommendations